ArticleOncotarget2014

GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.

Wan-Ling Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.